Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Medipharm Labs Corp (MEDIF)

Medipharm Labs Corp (MEDIF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.4300 +10.84%
on 06/21/19
4.7600 -20.13%
on 05/28/19
-0.9632 (-20.21%)
since 05/24/19
3-Month
2.1600 +76.01%
on 03/25/19
5.6500 -32.71%
on 05/22/19
+1.4867 (+64.22%)
since 03/22/19

Most Recent Stories

More News
MediPharm Labs Receives Permits and Ships First Medical Cannabis Concentrate to Australia

MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm Labs" or the "Company"), a leader in specialized, research-driven cannabis extraction and cannabinoid isolation, is pleased to announce...

MEDIF : 3.8018 (+2.61%)
ACNNF : 0.2500 (+0.81%)
LABS.VN : 4.960 (+2.69%)
Lucrative High-Quality CBD Market Beckons Suppliers With Best Extraction Methods

With each new market cannabidiol (CBD) expands into, an ever greater need for regulatory safeguards come into play to ensure safety and consistency of the quality of products in the market. This draws...

STIL.CN : 0.990 (unch)
VGW.CN : 4.280 (+4.39%)
MEDIF : 3.8018 (+2.61%)
VGWCF : 3.2400 (+3.46%)
RDDTF : 0.6100 (-0.20%)
SCNNF : 0.7635 (+0.58%)
NEPT.TO : 5.84 (+1.57%)
NEPT : 4.44 (+1.60%)
UPDATE - New York City Icahn School of Medicine at Mount Sinai and Renowned Global Researcher Dr. Hurd, Select MediPharm Labs to Support 500 Patient Major Clinical Study And "CBD International Consortium" to Develop Treatment of Opioid Addiction

MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE:MLZ) ("MediPharm Labs") a leader in specialized, research-driven cannabis extraction and cannabinoid isolation, is pleased to announce it has been...

MEDIF : 3.8018 (+2.61%)
LABS.VN : 4.960 (+2.69%)
Cronos Group and MediPharm Labs Enter $30 Million Multi-Year Private Label Cannabis Concentrate Supply Agreement with Potential to Increase to $60 Million

MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) ("MediPharm Labs") a leader in specialized, research-driven cannabis extraction and cannabinoid isolation, is pleased to announce that it has entered into...

CRON : 16.09 (+0.94%)
MEDIF : 3.8018 (+2.61%)
CRON.TO : 21.34 (+1.33%)
LABS.VN : 4.960 (+2.69%)
Cronos Group and MediPharm Labs Enter Cannabis Concentrate Supply Agreement

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos Group" or the "Company"), is pleased to announce that it has entered into a multi-year supply agreement with MediPharm Labs Corp. (TSXV: LABS) (OTCQX:...

CRON : 16.09 (+0.94%)
MEDIF : 3.8018 (+2.61%)
CRON.TO : 21.34 (+1.33%)
LABS.VN : 4.960 (+2.69%)
Cannabis Legalization Efforts Perk Up With Growing Medical Backing

The cannabis industry made significant progress in 2018, however, many challenges still lie ahead. Last year, the industry reached historic milestones as Canada fully legalized cannabis and numerous other...

KSHB : 4.4616 (+1.63%)
ORHOF : 6.6248 (-2.60%)
MEDIF : 3.8018 (+2.61%)
OH.CN : 8.750 (-2.67%)
ACRGF : 19.4115 (+1.63%)
NEPT.TO : 5.84 (+1.57%)
LABS.VN : 4.960 (+2.69%)
ACRG-U.CN : 19.410 (+0.31%)
NEPT : 4.44 (+1.60%)
Major Retailers Stock CBD Products as Consumers Focus on Health

When it comes to health and wellness, people have become more conscious about their daily lifestyle habits. According to a study by Nielsen, consumers are seeking functional foods that can help prevent...

SRNE : 3.70 (-5.85%)
MEDIF : 3.8018 (+2.61%)
HEXO : 5.36 (-4.11%)
ITHUF : 3.0012 (-4.12%)
OGRMF : 8.3500 (+4.64%)
OTCM : 33.5000 (+3.08%)
IAN.CN : 3.960 (-1.74%)
OGI.VN : 8.270 (-3.27%)
LABS.VN : 4.960 (+2.69%)
HEXO.TO : 7.06 (-4.59%)
Researchers Seek to Solidify Cannabis' Medical Credibility Around the Globe

Dozens of countries around the world have moved to legalize cannabis in some form, even though the majority of these countries are only allowing cannabis for medical applications. Research has linked cannabis'...

ACB : 7.51 (+2.88%)
MO : 48.49 (+1.02%)
TCNNF : 10.6300 (-4.23%)
ENW.VN : 2.370 (-4.44%)
APHA.TO : 9.35 (+3.66%)
LABS.VN : 4.960 (+2.69%)
TRUL.CN : 13.930 (-4.65%)
ACB.TO : 9.94 (+3.01%)
CRON : 16.09 (+0.94%)
ACBFF : 8.6900 (-12.80%)
MEDIF : 3.8018 (+2.61%)
APHA : 7.11 (+5.65%)
CRON.TO : 21.34 (+1.33%)
MediPharm Labs Announces Upgrade to the OTCQX Best Market in the U.S. Under Symbol "MEDIF"

MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm Labs" or the "Company") a global leader in specialized, research-driven cannabis extraction, distillation, purification and cannabinoid...

MEDIF : 3.8018 (+2.61%)
OTCM : 33.5000 (+3.08%)
LABS.VN : 4.960 (+2.69%)
OTC Markets Group Welcomes MediPharm Labs Corp. to OTCQX

NEW YORK , May 2, 2019 /PRNewswire/ --   OTC Markets Group Inc.  (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced MediPharm Labs Corp....

MEDIF : 3.8018 (+2.61%)
OTCM : 33.5000 (+3.08%)
LABS.VN : 4.960 (+2.69%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Trade MEDIF with:

Key Turning Points

2nd Resistance Point 4.1200
1st Resistance Point 3.9609
Last Price 3.8018
1st Support Level 3.5457
2nd Support Level 3.2896

See More

52-Week High 5.6500
Fibonacci 61.8% 3.8403
Last Price 3.8018
Fibonacci 50% 3.2813
Fibonacci 38.2% 2.7222
52-Week Low 0.9125

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar